Not logged inTWO-YEAR EFFECTIVENESS, DURABILITY AND SAFETY OF FARICIMAB IN EYES WITH DIABETIC MACULAR OEDEMA: RESULTS FROM THE UK FARWIDE-DMO STUDY
Peto, T.; Kiire, C.; Reynolds, R.; Sivaprasad, S.; Bailey, C.; Downey, L.; Pearce, I.; Chi, G. C.; Darnell, A.; Dayal, P. .png)
Share.png)
SavePREDICTING ANTI-VEGF OUTCOMES IN CENTRE-INVOLVING DIABETIC MACULAR OEDEMA USING REGRESSION AND MULTIMODAL DEEP LEARNING: A REAL-WORLD NHS COHORTAl-Zubaidy, M.; Stankiewicz, A.; Tsaberiaba, H.; McNally, T.; Rovati, M.; Anderson, M.; Obara, B.; Pohler, R.; Habib, M.; Steel, D. H. W. Share Save Challenges and Potential Solutions to Advance Global Cancer Drug DevelopmentGlasmacher, Axel; Lyerly, Kim; Wolf, Birgit; Zapella, Pio; Zielinska, Lidia; Clark, Emma; Mauer, Murielle; Paiva, Bruno; Schiel, Anja; Sweeney, Fergus; Uyl-de Groot, Carin A.; Von Lilienfeld-Toal, Marie; Verweij, Jaap Share Save Share Save Recommendations for overcoming methodological challenges to health economic modelling that arise when comparing in vitro diagnostics with imaging testsWatts, Karina; Garay, Osvaldo Ulises; Ferrante di Ruffano, Lavinia; Kittel, Phillip; Gregg, Emily; Heller, Vincent; Watkins, Deborah; Allen, A. Joy; Shinkins, Bethany; Mallet, Sue; Mealing, Stuart; Holmes, Hayden Share Save Evaluating the statistical utility and information loss in the transformation of a real-world oncology database from CDISC-SDTM to OMOP-CDMLambert, A.; Castagne, C.; Pau, D.; Chmiel, J.; Labarga, A.; Boernert, E.; Margraff, F.; Bachot, C.; Kaczmarek, L.; Toshev, D.; Martinez, J.; Stone, T. Share Save Evaluation of Current Statistical Methods for Implementing Quality Tolerance LimitsKilaru, Rakhi; Amodio, Sonia; Li, Yasha; Zeng, Yuling; Khaplonov, Arseny; Wang, Zhongkai; Wells, Christine; Love, Sharon; Rolfe, Tim; Talbot, Susan Share Save Quantitative relationship between tominersen concentrations in cerebrospinal fluid and biomarker changes in Huntington's disease patientsYamamoto, Yumi; Silber Baumann, Hanna E.; Bjornsson, Marcus; Grimsey, Paul; Hawellek, David J.; Anderson, Karen; Leavitt, Blair R.; Landwehrmeyer, Bernhard G.; Tabrizi, Sarah; Mccolgan, Peter; Wild, Edward J.; Sanwald Ducray, Patricia Share Save Share Save Effects of obinutuzumab on urinary renal biomarkers in lupus nephritis: a post hoc exploratory analysis of the phase II nobility studyVilet, Juan Manuel Mejia; Clarke, Holly J.; Lanza, Ben; Anania, Veronica; Pendergraft, William F.; Omachi, Theodore A.; Parodis, Ioannis; Jones, Rachel B.; Lightstone, Liz; Rovin, Brad; Raghu, Harini Share Save Share Save Share Save A Phase 2b, multicenter, randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of intravenous prasinezumab in early-stage Parkinson's disease (PADOVA): Rationale, design, and baseline dataNikolcheva, Tania; Pagano, Gennaro; Pross, Nathalie; Simuni, Tanya; Marek, Kenneth; Postuma, Ronald B.; Pavese, Nicola; Stocchi, Fabrizio; Seppi, Klaus; Monnet, Annabelle; Shariati, Nima; Ricci, Benedicte; Rutten-Jacobs, Loes; Respondek, Gesine; Kustermann, Thomas; Taylor, Kirsten I.; Trundell, Dylan; Fontoura, Paulo; Doody, Rachelle; Svoboda, Hanno; Bonni, Azad; Prasinezumab Study Grp Share Save CANBERRA: A Phase II Randomized Clinical Trial to Test the Therapeutic Potential of Oral Vicasinabin in Diabetic RetinopathyArmendariz, Beatriz G.; Luhman, Ulrich F. O.; Berger, Brian; Hernandez-Sanchez, Jules; Bogman, Katrijn; Mitrousis, Nikolaos; Wollenhaupt, Martina; Kent, David; Wenzel, Andreas; Fauser, Sascha Share Save Estimation of and clinical consensus on the meaningful motor progression threshold on MDS-UPDRS Part IIITrundell, Dylan; Davies, Evan W.; Barrett, Louise; Zanigni, Stefano; Shariati, Nima; Rogers, Rebecca; Monnet, Annabelle; Moore, Emma; Pross, Nathalie; Pagano, Gennaro; Cano, Stefan; Nikolcheva, Tania Share Save Immunologic investigations into transgene directed immune-mediated myositis following delandistrogene moxeparvovec gene therapyPotter, Rachael A.; Moeller, Ida H.; Khan, Sohrab; Haegel, Helene; Hollenstein, Andreas; Steiner, Guido; Wandel, Christoph; Murphy, Alexander P.; Asher, Damon R.; Palatinsky, Emanuel; Griffin, Danielle A.; Mason, Stefanie; Iannaccone, Susan T.; Zaidman, Craig M.; Rodino-Klapac, Louise R. Share Save Share Save Efficacy, durability and safety of faricimab for patients with neovascular age-related macular degeneration: 48-week results from the phase 3 LUCERNE China subpopulationZou, Wenjun; Jiang, Qin; Wang, Yanling; Wei, Wenbin; Sun, Xiaodong; Basu, Karen; Chen, Qiuyu; Kotecha, Aachal; Li, Sijing; Liu, Ruyuan; Patel, Vaibhavi; Chen, Youxin Share Save Subcutaneous ocrelizumab in multiple sclerosis: Results of the Phase 1b OCARINA I studyNewsome, Scott D.; Goldstick, Lawrence; Robertson, Derrick S.; Bowen, James D.; Naismith, Robert T.; Townsend, Ben; Figueiredo, Catarina; Kletzl, Heidemarie; Giraudon, Mylene; Bortolami, Oscar; Zecevic, Dusanka; Giacobino, Caroline; Clinch, Susanne; Shen, Yun-An; Deol-Bhullar, Gurpreet; Bermel, Robert A. Share Save Share Save 
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
